共 50 条
- [21] How I treat von Willebrand diseaseTHROMBOSIS RESEARCH, 2020, 196 : 618 - 625Castaman, Giancarlo
- [22] How I treat von Willebrand diseaseBLOOD, 2009, 114 (06) : 1158 - 1165Rodeghiero, FrancescoCastaman, GiancarloTosetto, Alberto
- [23] The von Willebrand disease Prophylaxis Network: exploring a treatment conceptJOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (11) : 2511 - 2512Berntorp, E.Abshire, T.
- [24] The Potential Role of Emicizuamb Prophylaxis in Severe Von Willebrand DiseaseBLOOD, 2020, 136Barg, Assaf ArieKenet, GiliLivnat, TamiAvishai, EinatBudnik, IvanBrutman-Barazani, TamiTamarin, IliaLubetsky, AharonBashari, DaliaDardik, RimaLalezari, ShadanMisgav, Mudi
- [25] The role of prophylaxis in the management of von Willebrand disease: today and tomorrowTHROMBOSIS RESEARCH, 2009, 124 : S15 - S19Abshire, Thomas
- [26] The potential role of emicizumab prophylaxis in severe von Willebrand diseaseBLOOD CELLS MOLECULES AND DISEASES, 2021, 87Barg, Assaf A.Avishai, EinatBudnik, IvanBrutman, Tamar BarazaniTamarin, IliaDardik, RimaBashari, DaliaMisgav, MudiLubetsky, AharonLalezari, ShadanLivnat, TamiKenet, Gili
- [27] PROPHYLAXIS WITH RECOMBINANT VON WILLEBRAND FACTOR IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE: PHASE 3 TRIAL RESULTSAMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E62 - E63Leebeek, Frank W. G.Peyvandi, FloraEscobar, MiguelTiede, AndreasCastaman, GiancarloGu, JoanMellgard, BjornEwenstein, BruceOzen, Gulden
- [28] Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study resultsBLOOD, 2022, 140 (02) : 89 - 98Leebeek, Frank W. G.Peyvandi, FloraEscobar, MiguelTiede, AndreasCastaman, GiancarloWang, MichaelWynn, TungBaptista, JovannaWang, YiZhang, JingmeiMellgard, BjornOzen, Gulden
- [29] RETROSPECTIVE REVIEW OF FOUR DAYS OF VON WILLEBRAND'S FACTOR AS SURGICAL PROPHYLAXIS IN VON WILLEBRAND'S DISEASEHAEMATOLOGICA, 2017, 102 : 401 - 402Bal, S.Riaz, M. K.Peters, D.Palascak, J.Girnius, S.